A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
AstraZeneca
Incyte Corporation
Mersana Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Nammi Therapeutics Inc
Regor Pharmaceuticals Inc.
Fate Therapeutics
Conjupro Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Conjupro Biotherapeutics, Inc.
Cogent Biosciences, Inc.
EMD Serono
GlaxoSmithKline
SystImmune Inc.
M.D. Anderson Cancer Center
Institut Paoli-Calmettes
Orano Med LLC
Eli Lilly and Company
Eli Lilly and Company
Atavistik Bio, Inc
NiKang Therapeutics, Inc.
Alterome Therapeutics, Inc.
BeOne Medicines
ViroMissile, Inc.
Myeloid Therapeutics
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Poseida Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
Avacta Life Sciences Ltd
SystImmune Inc.
SN BioScience
M.D. Anderson Cancer Center
Eli Lilly and Company
Shanghai Best-Link Bioscience, LLC
University of Washington
Fusion Pharmaceuticals Inc.
M.D. Anderson Cancer Center
OncoNano Medicine, Inc.
National Institutes of Health Clinical Center (CC)
MOMA Therapeutics
Risen (Suzhou) Pharma Tech Co., Ltd.
NextCure, Inc.
Nuvation Bio Inc.
SystImmune Inc.